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Several determinants that appear to promote the dimerization of murine retroviral genomic RNA have been
identified. The interaction between these determinants has not been extensively examined. Previously, we
proposed that dimerization of the Moloney murine sarcoma virus genomic RNAs relies upon the concentration-
dependent interactions of a conserved palindrome that is initiated by separate G-rich stretches (H. Ly, D. P.
Nierlich, J. C. Olsen, and A. H. Kaplan, J. Virol. 73:7255–7261, 1999). The cooperative action of these two
elements was examined using a combination of genetic and antisense approaches. Dimerization of RNA
molecules carrying both the palindrome and G-rich sequences was completely inhibited by an oligonucleotide
complementary to the palindrome; molecules lacking the palindrome could not dimerize in the presence of
oligomers that hybridize to two G-rich sequences. The results of spontaneous dimerization experiments also
demonstrated that RNA molecules lacking either of the two stretches of guanines dimerized much more slowly
than the full-length molecule which includes the dimer linkage structure (DLS). However, the addition of an
oligonucleotide complementary to the remaining stretch of guanines restored the kinetics of dimerization to
wild-type levels. The ability of this oligomer to rescue the kinetics of dimerization was dependent on the
presence of the palindrome, suggesting that interactions within the G-rich regions produce changes in the
palindrome that allow dimerization to proceed with maximum efficiency. Further, unsuccessful attempts to
produce heterodimers between constructs lacking various combinations of these elements indicate that the
G-rich regions and the palindrome do not interact directly. Finally, we demonstrate that both of these elements
are important in maintaining efficient viral replication. Modified antisense oligonucleotides targeting the DLS
were found to reduce the level of viral vector titer production. The reduction in viral titer is due to a decrease
in the efficiency of viral genomic RNA encapsidation. Overall, our data support a dynamic model of retroviral
RNA dimerization in which discrete dimerization elements act in a concerted fashion.
Each retroviral particle contains two plus-strand molecules
of the viral genomic RNA. The two molecules are nonco-
valently linked near their 59 ends in a region known as the
dimer linkage structure (DLS); numerous studies have sug-
gested that maintenance of the RNA dimer plays an important
role in a number of steps in viral replication (reviewed in
reference 22).
Despite the preponderance of evidence supporting a re-
quirement that retroviral RNAs form dimers, the exact nature
of the DLS has not been clearly defined. The results of electron
microscopy and sedimentation studies indicate that the two
RNAs are held together noncovalently near their 59 ends (3, 9,
11, 18). Several investigators have identified a number of po-
tential cis-acting determinants of dimerization in this region,
although the precise role(s) played by each determinant in
promoting dimer formation remains obscure. A phylogeneti-
cally conserved palindrome has been identified in the 59 un-
translated region and has been demonstrated to be an impor-
tant determinant of dimerization in some studies (5, 7, 8, 17,
23–26). Other investigators have emphasized the role of con-
served purine motifs in promoting dimerization through the
formation of purine quartets (1, 2, 15, 29). Finally, Oroudjev
and colleagues identified a conserved stem-loop structure up-
stream of the palindrome that appears to support dimerization
in vitro (20).
Recently, we proposed a model for the dimerization of
Moloney murine sarcoma virus (MuSV) DLS RNA in which
two downstream G-rich regions act in concert with the palin-
drome to allow dimerization to proceed (12). This study ex-
tends those observations by examining the function of these
determinants in an in vitro dimerization system and the impact
these determinants have on viral replication. Using a combi-
nation of genetic and antisense approaches, we demonstrate
that interactions in the G-rich regions enhance the rate of
dimerization and that this effect is mediated through the pal-
indrome. Overall, our experimental results suggest that dimer-
ization of the MuSV DLS RNA is promoted by the coordi-
nated action of several redundant RNA determinants and that
the presence of these determinants plays an important role in
viral replication.
MATERIALS AND METHODS
Preparation of RNA samples. The pLNBS plasmid is a modified version of the
pLNL6-based pLN plasmid (J. C. Olsen, unpublished data) containing the MuSV
DLS and a neomycin resistance gene (described previously [12]). Numbering of
the nucleotides is assigned according to the recently submitted MuSV sequence
to GenBank (AF033813).
DNA fragments used as templates in the in vitro transcription reaction were
synthesized via PCR amplification using the MuSV DLS region of pLNBS as a
template. The forward primers contain a T7 promoter sequence and sequences
identical to either the primer-binding site (PBS) at nucleotide (nt) 105 (59TAA
TACGACTCACTATAGGGCGATGGGGGCTCGTCCGGGAT39) or the BsiE I
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site at nt 310 (59GAACATAATACGACTCACTATAGGGCGACCCGGCCG
CA39). The reverse primer begins at the putative initiation site of the gag gene
(position 557) and ends at position 535 (59CTAATTTTCAGACAAATACAG
AAAC39). PCR products were analyzed on a 1.0% agarose gel prior to purifi-
cation using a QIAquick PCR purification kit (Qiagen, Valencia, Calif.). Samples
were eluted from the columns with 50 ml of RNase-free water (Sigma, St. Louis,
Mo.).
Transcription mixtures (20 ml) contained 1 mg of DNA template, 0.5 mM
(each) unlabeled ATP, GTP, UTP, 50 mM unlabeled CTP, and 2.5 mM
[a-32P]CTP (Amersham, Arlington Heights, Ill.). The reaction was performed
with a T7 MAXIscript kit as suggested by the manufacturer (Ambion, Austin,
Tex.). RNA transcripts were separated by electrophoresis on 5% polyacrylamide
(PA)–8 M urea gels at 250 V for 2 h in 13 TBE buffer (90 mM Tris-borate, 2 mM
EDTA). RNA samples were eluted from gels with elution buffer (Ambion). The
purified RNAs were then ethanol precipitated and resuspended in 100 ml of
water (Sigma) and stored at 270°C. The products were quantified with a Beck-
man LS6500 scintillation counter. Full-length RNA transcript refers to in vitro-
transcribed MuSV RNA that contains an unaltered DLS signal.
RNA dimerization assay. For a standard dimerization assay, 8-ml portions of
;1.5 nM a-32P-labeled RNA were heated at 95°C for 3 min, chilled on ice for 3
min, and 2 ml of D53 buffer (500 mM NaCl, 250 mM Tris-HCl [pH 7]) were
added. The samples were then incubated at 60°C for 1 h. The samples were
chilled and separated by electrophoresis on 5% nondenaturing polyacrylamide
gels in the presence of 13 TBE buffer. Gels were dried and exposed directly on
a phosphorimager screen for 18 to 20 h. The amount of dimer formation was
quantitated using a model 445SI PhosphorImager system and ImageQuaNT
image analysis software. The fraction of RNA in dimeric form was estimated by
taking the ratio of dimeric RNA to the sum of both the monomeric and dimeric
species. Dimer inhibition assays were carried as outlined above except that
antisense oligonucleotides (60 mM) (Table 1) were added before heat de-
naturation. In some instances, the oligonucleotides were 59 end labeled with
[g-32P]ATP using bacteriophage T4 polynucleotide kinase (Gibco-BRL, Grand
Island, N.Y.). The labeled oligomers were purified through a G-25 column
(Amersham). The kinetic comparisons of f105-557, f105-557DPal, and f105-
557DG5 RNAs were done in a manner similar to the standard dimerization
reaction, except that the incubation times varied as indicated in the figures and
that f105-557DPal was incubated at 55°C rather than at 60°C (see Fig. 4A). To
assay heterodimer formation, various RNA fragments, each at 1.5 nM concen-
tration, were combined and used in the standard dimerization assay (see Fig. 5).
Cell culture, transfections, and infections. GP 1 E86 murine ecotropic pack-
aging cells (12), PA-317 murine amphotropic packaging cells (ATCC CRL 9078),
and NIH 3T3 murine fibroblast cells (ATCC CRL 1658) were maintained in
Dulbecco’s modified Eagle’s medium containing a high level of glucose (4.5
g/liter) and 10% newborn calf serum, 10% fetal calf serum, and 10% calf serum,
respectively. The polyclonal cell line expressing the wild-type MuSV DLS se-
quence was made by first transfecting 5.0 3 105 PA-317 cells with 20 mg of
pLNBS DNA by calcium phosphate precipitation (Calcium Phosphate Transfec-
tion System; Gibco-BRL).
Virus particles were collected from the transfection supernatant 48 h post-
transfection. Various concentrations of the viral supernatants (102- to 105-fold
dilutions) were used to infect 2.5 3 105 GP 1 E86 cells in the presence of 8 mg
of Polybrene per ml as described previously (19). G418-resistant colony forma-
tion was measured in medium supplemented with 500 mg of Geneticin (Gibco-
BRL) per ml (19). Approximately 200 G418-resistant colonies were trypsinized,
pooled, and stored in freezing solution Dulbecco’s modified Eagle’s medium
containing a high level of glucose [4.5 g/liter], 10% fetal calf serum, 10% di-
methyl sulfoxide).
Prior to treatment with morpholino oligonucleotides (GeneTools, LLC, Cor-
vallis, Oreg.), 5 3 105 polyclonal cells expressing the wild-type MuSV DLS
sequence (passage 39) were seeded into each well of a six-well culture plate in 1
ml of growth medium lacking Geneticin. Morpholino oligonucleotide is a mod-
ified nucleotide analog in which the deoxyribose moiety of DNA is replaced by
a six-membered morpholine ring and the charged phosphodiester nucleoside
linkage is substituted by an uncharged phosphoramidate bond (28). The oligo-
nucleotides were introduced into the polyclonal cells by the method of Summer-
ton et al. (27). Briefly, 24 h postseeding, the cell medium was replaced with 1 ml
of fresh medium containing 10 mM morpholino oligonucleotide. Cells were
gently scraped off the surface of the well with a sterile cell scraper (Costar,
Cambridge, Mass.) and transferred to a new well. The medium, containing
released virus particles, was collected 24 h later and filtered through a 0.2-mm-
pore-size filter (Schleicher & Schuell, Keene, N.H.). Viral titers were determined
by measuring G418-resistant colony formation on NIH 3T3 cells as described
previously (12, 19).
RT-PCR analyses. Viral genomic RNAs from oligomer-treated and untreated
samples were isolated from cells and viral supernatants using the Trizol reagent
(Gibco-BRL) and the Qiagen viral RNA miniprep kit (Qiagen), respectively.
Prior to RNA extraction, the virus supernatants were concentrated via centrif-
ugation at 25,000 rpm (Tomy TX-160) for 30 min. The sample was treated with
10 U of RQ1 DNase in 13 DNase buffer for 1 h at 37°C (Promega, Madison,
Wis.). The RNAs were extracted with phenol-chloroform and precipitated with
ammonium acetate as previously described (12). Similar DNase treatment (mi-
nus the phenol-chloroform extraction step) was applied to the virus supernatants
prior to RNA extraction. Cell-isolated RNA (1.0 mg) (optical density at 260 nm)
and various volumes of virion-isolated RNA (5, 10, and 20 ml) were each used as
the template in the single-step reverse transcriptase PCR (RT-PCR) as sug-
gested by the manufacturer (18 cycles at 55°C annealing temperature) (Ambion).
The oligonucleotides used in the RT-PCR are RTPCRup primer (59GTTATG
CGCCTGCGTCTGTACT39) and RTPCRdn primer (59CATATCCTGACGG
GGTCGGA39), which correspond to viral nt 223 to 244 and 387 to 406, respec-
tively. RTPCRup primer (50 mM) was 59 end labeled with [g-32P]ATP using
bacteriophage T4 polynucleotide kinase (Gibco-BRL). A mixture of control
primers (50 mM) (Ambion), which correspond to the constitutively expressed
cellular ribosomal protein S15 subunit, was also 59 end labeled. The labeled
products were purified through a G-25 column (Amersham). Each primer (5
mM) was used in the one-step RT-PCR as suggested by the manufacturer (Am-
bion). A quarter of the PCR product was denatured (95°C for 5 min) and
separated on a 5% PA–8 M urea gel at 150 V. PhosphorImager and related
TABLE 1. Sense and antisense oligonucleotides
Oligonucleotidea Sequence (59-39)b Tm (°C)c
Unmodified
antiPBS (106–123) ATCCCGGACGAGCCCCCA 74
antiPal-30 (240–269) CAGATACAGAGCTAGTTAGCTAACTAGTAC 75
antiPal-21 (240–260) AGCTAGTTAGCTAACTAGTAC 65
antiG5 (334–349) AACGGCCCCCAAAGTC 65
antiG3 (364–380) ATCGACTCCCTTCCTCA 64
Morpholino
antiPBS (95–119) CGGACGAGCCCCCAAATGAAAGACC 79
antiPal (229–253) TAGCTAACTAGTACAGACGCAGGCG 76
antiG5 (332–356) CCACAAAAACGGCCCCCAAAGTCCC 79
antiG3 (363–387) ATTCCACATCGACTCCCTTCCTCAG 76
antiCon1 (285–306) GGGTGTTCAGAACTCGTCAGT 71
antiCon2 (308–327) ACGTCTCCCAGGGTTGCGGC 76
revNeo (1651–1675) AAGCGTACTAACTTGTTCTACCTAA 69
antiNeo (1651–1675) AATCCATCTTGTTCAATCATGCGAA 69
Standard CCTCTTACCTCAGTTACAATTTATA
a Numbering in parentheses is with respect to the MuSV viral mRNA (GenBank accession no. AF33813). For revNeo and antiNeo, the positions of the nucleotides
are with respect to those of the retroviral vector pLNL6 (GenBank accession no. M63653). The sequence of revNeo is identical to that of the antiNeo oligomer, but
the orientation of revNeo is opposite that of antiNeo. antiNeo is an antisense oligonucleotide that hybridizes to the initiation site of the neomycin phosphotransferase
gene. Standard, control oligonucleotide of randomized sequence, supplied by GeneTools, LCC.
b Sequences are antisense in polarity with respect to the viral mRNA except where indicated (i.e., revNeo).
c Melting temperature of oligonucleotides is calculated by the %GC method.
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softwares (Molecular Dynamics) were used to quantify the PCR products on the
gels (see Fig. 6A).
RNase H cleavage assay. Mixtures of DLS RNA transcripts (1.5 nM) and
either modified (morpholino) or unmodified DNA oligomers (60 mM) were
allowed to anneal by heating the samples to 95°C for 3 min and cooling on ice.
After adding the First-Strand MuLV RT buffer (13) (Gibco-BRL), the samples
were allowed to dimerize at 60°C for 1 h. At the end of the incubation time,
samples were again chilled on ice for 3 min prior to the addition of 10 U of
MuLV RT enzyme (Gibco-BRL). The mixtures were then incubated at 37°C for
an additional hour before being denatured and separated on 5% PA–8 M urea
gels (see Fig. 7).
RESULTS
Antisense DNA oligonucleotides binding to the palindrome
or G-rich regions alter in vitro dimerization of MuSV DLS
RNA. We began by examining the effects of antisense DNA
oligonucleotides on spontaneous dimer formation of a region
of the MuSV genome containing the DLS (Fig. 1). Initially,
antisense DNA oligonucleotides binding to various regions of
the DLS were tested to determine whether they would inter-
fere with the dimerization of the full-length DLS RNA (f105-
503), which contains both the palindrome and G-rich se-
quences (Fig. 2). Although oligonucleotides binding to the
palindrome (antiPal) effectively inhibited dimer formation of
the full-length DLS RNAs, other oligonucleotides targeting
either the PBS or the G-rich sequences had little effect (Fig. 2,
compare lane 4 to lanes 3, 5, and 6).
We extended these observations by examining the dimeriza-
tion of a DLS fragment lacking the palindrome (f310-557)
(Fig. 3). In contrast to the full-length fragment (f105-503),
spontaneous dimerization of this fragment (f310-557) was in-
hibited by the addition of a combination of oligonucleotides
directed against both G-rich regions (antiG3 and antiG5). For-
mation of dimers did not appear to be affected by the addition
of either antiG3 or antiG5 oligonucleotides alone. However,
the addition of antiG3 and antiG5 oligomers also effectively
inhibited dimerization of the full-length DLS fragment con-
taining a 10-nt deletion within the palindrome (data not
shown). Of note, experiments using radiolabeled oligonucleo-
tides with unlabeled DLS RNA indicate that the antiG3 and
antiG5 oligonucleotides bind to both dimeric and monomeric
forms of the genomic RNA (Fig. 3, lanes 3’ to 5’). The inhib-
itory effect of the oligomers was not as pronounced at high
concentrations of RNA, however (compare Fig. 2 and 3).
RNA molecule lacking one of the G-rich sequences (f105-
557DG5) dimerizes more slowly than wild type but can be
kinetically enhanced by an antiG3 oligomer. Our previous
study indicated that at low concentration, the dimerization of
MuSV DLS RNA is initiated by contact between the G-rich
sequences (12). The effects of these determinants on the rate
of dimerization were examined by assaying the conversion of
monomers to dimers over time.
Dimerization of a full-length DLS fragment lacking either
the palindrome (f105-557DPal) (Fig. 4A, lanes 6 to 10) or one
FIG. 1. (A) Representation of the MuSV genome. Numbering is with respect to the viral mRNA, which begins at the transcriptional start site and ends at the
poly(A) site (GenBank accession no. AF033813). Viral long terminal repeats, the gag, pol, and v-mos genes, and the sequences of interest (i.e., PBS, DLS, the Pal
palindrome, G5 and G3 G-rich motifs, and the gag initiation site AUG) are shown. (B) The primary DLS sequence and antisense oligonucleotides are shown. Solid
underlines indicate the positions of the modified (morpholino) oligonucleotides relative to the primary sequence. Broken underlines show the positions of the
unmodified oligonucleotides. Oligonucleotides: 1 and 1’, modified and unmodified antiPBS, respectively; 2 and 2’, modified and unmodified antiPal, respectively; 3,
modified antiCon1; 4, modified antiCon2; 5 and 5’, modified and unmodified antiG5; and 6 and 6’, modified and unmodified antiG3, respectively. See Table 1 for the
sequences of the antisense oligonucleotides. The positions of the PBS, Pal, G5, and G3 sequences are shown in boldface and are noted above the sequences.
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of the G-rich stretches (f105-557DG5) (lanes 11 to 15) was
slower than dimerization of the wild-type fragment (lanes 1 to
5). In contrast to the wild-type fragment, for which dimers were
apparent by 7.5 min (lane 2), dimerization of a fragment miss-
ing the stretch of five guanines was not appreciable until 30
min had elapsed (lane 14). However, when the incubation time
was extended to more than 6 h, dimerization of f105-557DG5
reached the same level as that of the full-length f105-557 frag-
ment (Fig. 4B).
Remarkably, the addition of the antiG3 oligonucleotide to
the construct lacking the G5 sequence (f105-557DG5) restored
the rate of dimerization (Fig. 4A, lanes 16 to 20). Dimerization
of this RNA in the presence of the antiG3 oligomer followed
the same kinetics as the full-length fragment (Fig. 4B). The
FIG. 2. Dimerization of the full-length RNA (f105-503) is inhibited by the antiPal oligonucleotide. a-32P-labeled RNA (1.5 nM) was incubated with various
unlabeled oligonucleotides (60 mM) at 60°C for 1 h before separation on a 5% nondenaturing PA gel as described in Materials and Methods. Whenever a combination
of oligonucleotides was used (lanes 7 and 8), the final concentration of each oligonucleotide was 30 mM. Pal palindromic sequence and G5 and G3, two consecutive
guanines, are shown at the top. The positions of monomeric RNA (M) and dimeric RNA (D) are shown to the right of the gel. The oligonucleotides are given over
the lanes (No Oligo, no oligonucleotides; a, anti).
FIG. 3. Dimerization of an RNA molecule lacking the Pal sequence (f310-557) is inhibited by a combination of the antiG-rich oligonucleotides. Unlabeled f310-557
(1 mg) was dimerized in the presence of 60 mM 59-end-labeled DNA oligonucleotide for 1 h at 60°C prior to separation on a 5% PA gel. The RNA was stained with
100 mg of ethidium bromide per ml in 13 TBE buffer for 15 min (A). After being photographed, the gel was then dried and exposed directly onto a phosphorimager
screen for 18 to 20 h (B). The positions of monomeric RNA (M) and dimeric RNA (D) are shown to the right of the gel. The oligonucleotides are shown over the gel
(No Oligo, no oligonucleotides; a, anti).
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ability of this oligonucleotide to rescue dimerization was de-
pendent on the presence of the palindrome; the addition of the
antiG3 oligonucleotide had no effect on the rate of dimeriza-
tion for either the RNA in which the palindrome had been
deleted or for the wild-type DLS molecule (Fig. 4A, lanes 21 to
30).
Heterodimer formation data suggest that there is no direct
physical interaction between the palindrome and G-rich se-
quences. RNAs containing either one or both of the dimeriza-
tion determinants were used to evaluate whether there is a
direct physical interaction between the palindrome and G-rich
regions. We tested the ability of various truncated and full-
length DLS RNAs to form heterodimers. As expected, the
truncated RNA fragments could form homodimers efficiently
under the proper conditions (Fig. 5, lanes 1 to 4, 7, and 8).
Further, the truncated fragments could form heterodimers
with the full-length DLS RNAs (lanes 9 to 12). However, no
heterodimer formation was noted between two RNA frag-
ments which contained only the palindrome (f105-339) or the
G-rich motifs (f310-557) (lane 6). These results suggest that
the elements form discrete dimerization units and that there is
no direct interaction between them.
Viral vector production is impaired by antisense oligonucle-
otide targeting the DLS sequence. We also examined the roles
of these dimerization domains by attempting to inhibit viral
replication in a MuSV-based vector system using antisense
oligonucleotides that bind to these domains. These experi-
ments were performed by assessing the effects of morpholino
antisense oligonucleotides on viral titer (Table 2). Large effects
on titer were obtained by using the oligonucleotides that bound
FIG. 4. Dimerization of f105-557DG5 is delayed compared to that of the full-length f105-557, but it can be kinetically enhanced by the antiG3 (aG3) oligonucleotide.
(A) The standard dimer inhibition assay was conducted as outlined in Materials and Methods, except that the individual reaction was terminated by chilling on ice at
the end of the appropriate incubation times (0, 7.5, 15, 30, and 60 min) until separation on a 5% PA gel. (B) Kinetics of dimerization. The mean values (as percentages)
of the dimeric species of the RNA fragments in the presence or absence of the antiG3 oligomer (aG3) were plotted and compared. The standard deviation at each
time point is less than 8.0% for at least a duplicate set of reaction mixtures. WT, wild type (f105-557); DPal, f105-557DPal; DG5, f105-557DG5.
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to either the palindrome or the G5 region (Table 2). These
effects were comparable to those seen with an antisense oligo-
nucleotide complementary to the PBS and greater than the
decline in titer obtained with an antiNeo oligomer, which hy-
bridizes to the initiation site of the neomycin phosphotransfer-
ase gene. Little or no effect on titer was seen with several
control oligonucleotides that were complementary to se-
quences between the palindrome and G5 (antiGcon1 and an-
tiGcon2) (Fig. 1). We tested these oligomers because other
groups have suggested that these regions may play a role in
dimerization in vitro (16, 30).
Viral titer reduction can be attributed, in part, to the re-
duced efficiency of viral genomic RNA encapsidation. To help
define the point in the viral life cycle that was influenced by the
antisense oligonucleotide treatment, we decided to determine
the level of encapsidated genomic RNA (Fig. 6A). Both the
antiPal and antiG5 oligomers reduced the viral genomic RNA
packaging by approximately 70% relative to that of the un-
treated sample; treatment with the other oligomers had little
or no effect on the level of RNA encapsidation (Fig. 6B). The
moderate reductions in RNA packaging observed for the
oligomer-treated samples are consistent with the results ob-
tained from deletion analyses of these similar regions in the
related MuLV virus (16). As expected, no marked reduction
in viral RNA packaging was observed for the antiPBS and
antiNeo samples, although the titers produced from cells
treated with these oligomers were reduced by three- to six-
fold (Table 2).
FIG. 5. Heterodimer formation shows no direct interaction between the kissing loop and the G-rich sequences. The standard dimerization reaction was performed
as outlined (Materials and Methods) except that, in some instances, a combination of different RNAs (1.5 nM [each] RNA) was codimerized in a single reaction mixture
(lanes 6, 10, and 12). Also, reaction mixtures containing f105-339 RNA are supplemented with 0.5 mg of identical but unlabeled product. The different RNAs are
indicated by numbers as follows: 1, f105-339; 2, f310-557; 3, f105-557. The positions of monomeric RNA (M), dimeric RNA (D), and heterodimers (HD) are shown
to the left and right of the gel.
TABLE 2. Effects of antisense DNA oligonucleotide targeting the viral DLS region on viral replication
Treatment Titera Reduction in titer(fold)b
Relative fold reductionb in: Reduction in
packaged RNAscGenomic RNAs Virion RNAs
No oligonucleotide 3.70 (0.35) NAd 1.00 1.00 NA
antiPBS 0.51 (0.05) 6.00 0.95 (0.07) 0.66 (0.08) 1.44
antiPal 0.61 (0.01) 5.00 0.83 (0.25) 0.27 (0.02) 3.10
antiG5 0.50 (0.09) 7.70 0.81 (0.13) 0.26 (0.04) 3.12
antiG3 1.30 (0.07) 2.60 1.00 (0.01) 0.58 (0.01) 1.72
antiCon1 2.80 (0.63) 1.00 0.80 (0.22) 0.55 (0.05) 1.46
antiCon2 3.20 (0.64) 1.20 0.95 (0.07) 0.77 (0.05) 1.23
antiNeo 0.75 (0.14) 3.00 0.88 (0.18) 0.91 (0.16) 0.91
revNeo 2.90 (0.14) 1.20 0.93 (0.11) 0.97 (0.04) 1.02
Standard 2.30 (0.78) 2.00 0.83 (0.04) 0.75 (0.11) 1.11
a Titers (105 CFU per milliliter) of the MuSV vector from a representative experiment. The numbers in parentheses represent standard deviations.
b Mean values (fold reduction) normalized to the values for the untreated samples. Data are taken from at least two independent assays. The numbers in parentheses
represent standard deviations.
c Relative fold reduction of packaged RNAs 5 relative fold reduction of genomic RNAs/relative fold reduction of virion RNAs.
d NA, not applicable.
9942 LY ET AL. J. VIROL.
Hybridization of the antisense DNA oligomers to the target
RNA does not alter the integrity of the genomic RNA inside the
virions. We were concerned that the formation of RNA-DNA
hybrids produced by morpholino oligomer treatment may ren-
der the viral genome more susceptible to RNase H activity of
the viral RT inside the virions. To examine this possibility,
mixtures of viral DLS RNA and either modified (morpholino)
or unmodified DNA oligomers were allowed to anneal. The
mixtures were then treated with the MuLV RT enzyme and
separated on 5% PA–8 M urea gels (Fig. 7). While RT could
effectively cleave the target RNAs in the presence of the un-
modified oligomers (lanes 3, 5, and 7), it could not modify the
RNA samples that contained the modified oligomers (lanes 4,
6, and 8). These observations suggest that the morpholino
oligomers used in our viral culture system did not render the
viral genomic RNA susceptible to RT-associated RNase H
cleavage.
DISCUSSION
We previously demonstrated that spontaneous dimerization
of the MuSV DLS RNA is dependent upon the cooperative
interactions between the sequences that comprise the palin-
drome and the G-rich motifs (12). Here we extend these ob-
FIG. 6. Reduction of viral genomic RNA encapsidation due to antisense DNA oligomers. (A) RT-PCR amplification of viral genomic RNAs. Polyclonal cells
expressing the wild-type DLS sequence were treated either with one of a series of antisense DNA oligomers or with a medium control. RNAs were isolated from cells
or virions. Various volumes of virion-isolated RNAs (5, 10, and 20 ml [indicated by the height of the triangle over each set of three lanes]) and 1.0 mg of cell-isolated
RNAs were RT-PCR amplified. vRNA and S15 are PCR products amplified from viral RNA and control ribosomal protein S15 message, respectively. a, anti; (2) RT,
one-step RT-PCR mixture lacking MuLV RT; Water, one-step RT-PCR mixture lacking the RNA substrate. (B) Relative reduction of genomic RNA packaging.
Percentage reductions in genomic RNA encapsidation of the oligomer-treated samples relative to that of the untreated mixture were compared.
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servations by exploring the interactions between these two
domains. Our results support a role for both of these determi-
nants in promoting dimerization and suggest that the two do-
mains function cooperatively to allow dimerization to proceed
with maximum efficiency.
Our data demonstrate that an antisense oligonucleotide di-
rected against the palindrome is sufficient to block spontane-
ous dimerization of the full-length DLS fragment. Although
oligomers complementary to the G-rich regions were unable to
block dimerization of the full-length DLS molecule, they did
inhibit dimerization of RNAs lacking the palindrome. This
observation is consistent with a model in which the interaction
of the G-rich regions is in a pathway preceding the final state
of dimerization. Overall, the influence of the antisense oli-
gomers on in vitro dimerization is in keeping with a process in
which the two domains contribute to the formation of the
dimer.
It is interesting to note that when the antiG3 or antiG5
oligomers are added singly, they bind to both the dimeric and
monomeric forms of the RNA and do not appear to inhibit
dimerization of RNAs lacking the palindrome. Further, when
the radiolabeled antiG-rich oligomers are added together, they
produce a more intense monomer band (Fig. 3, lane 5’), sug-
gesting that either G-rich region can function in dimerization.
Overall, the results of these experiments combined with those
reported previously indicate that dimeric RNAs lacking the Pal
sequence are held together by the G-rich sequences and that
simultaneous hybridization of these elements by both antiG-
rich oligomers completely blocks dimer formation.
We noted that dimerization for an RNA molecule lacking
one of the G-rich regions is delayed. This delay is completely
rescued by the addition of a DNA oligomer that hybridizes to
the other stretch of guanines. Our results also demonstrate
that the ability of this antiG3 oligomer to promote dimeriza-
tion is dependent on the presence of the palindrome. There-
fore, it appears that an interaction in the region of the guanines
is required in order for dimerization to occur at the same rate
as the full-length DLS RNA and that this interaction is medi-
ated through the presence of the palindrome. This observation
supports the view of RNA dimerization as a dynamic process.
Our data are in accord with a dynamic model of the dimer-
ization of MuLV genomic RNA proposed by several investi-
gators (5, 8). De Tapia and colleagues have suggested that the
association of the palindromes is a slow process that is kinet-
ically enhanced by sequences downstream (5). In their model,
the initial interactions involve stem-loop structures down-
stream from the kissing loop that allow rapid structural rear-
rangement of the monomeric RNA. They propose that these
initial interactions increase the fraction of RNA conformers
that are available to dimerize via the palindrome (5). Accord-
ingly, the secondary structure of the MuLV DLS is predicted to
undergo dimerization-induced conformational changes, as in-
dicated by changes in reactivity to chemical probing agents in
solution (30). More specifically, besides the changes observed
for the kissing-loop structure, sequences downstream from it
are predicted to undergo almost complete structural rear-
rangement in the RNA dimer (29). It is interesting to note that
the five guanines deleted in the MuSV f105-557DG5 fragment
are analogous to a MuLV sequence predicted to be part of a
stem-loop structure that was proposed to participate in the
initial intermolecular interactions between RNA molecules (8).
Our data and the data of others suggest that rearrangements
in RNA determinants downstream from the palindrome ac-
company dimerization. However, the precise nature of these
interactions had not been defined and the possibility that these
determinants may interact directly with each other had not
FIG. 7. Effects of modified (Morph) and unmodified (Phos) antisense DNA oligomers (oligo) on the stability of the target RNA. Viral RNAs are cleaved by the
MuLV RT enzyme in the presence of unmodified DNA oligomers (lanes 3, 5, and 7) into the expected RNA products (antiPal [a Pal], 300- and 130-nt fragments; antiG5
[a G5], 210- and 220-nt fragments; antiCon1 [a Con1], 200- and 240-nt fragments). Viral RNAs are not altered in the presence of modified oligonucleotides (lanes 4,
6, and 8). The presence (1) or absence (2) of the RT enzyme is indicated over the gel.
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been examined. We addressed this question by attempting to
produce heterodimers between RNA molecules containing
one or both of these elements (Fig. 5). The results of these
experiments indicate that an RNA monomer containing only
one of these elements can pair only with a monomer containing
the same element. Therefore, although both the palindrome
and the downstream elements participate in the final dimer,
they do not appear to interact directly with each other. Overall,
these results are consistent with the data obtained from the
successful heterodimer formation between full-length DLS
RNAs from the various retroviruses (15) and suggest that these
elements form discrete dimerization domains.
The conclusion that both of these determinants play an
important role in dimerization and/or other aspects of viral
replication is further supported by our viral infectivity data. We
demonstrate that an oligomer complementary to either of the
stretches of guanines also has a significant effect on viral rep-
lication (Table 2). The reductions in viral vector titer can, in
part, be explained by the attenuation of the viral genomic RNA
encapsidation efficiency (Fig. 6). Nevertheless, the defect in
RNA packaging alone could not account for the full reduction
effect observed with the viral vector titer production. These
results suggest that aspects of viral replication other than RNA
encapsidation may be affected by changes that disrupt dimer-
ization.
Overall, our data support a multistage model of RNA dimer-
ization in which initial interactions between two RNA mole-
cules involve the regions encompassing the stretches of gua-
nines. These initial interactions induce subsequent changes in
the palindrome that allow dimerization to proceed. It has been
suggested that dimerization of the retroviral genomic RNA
plays an important role in several aspects of viral replication
including RNA encapsidation and reverse transcription (22). It
has also been noted that retroviral assembly is very efficient at
selectively packaging dimers of RNA of viral, but not cellular,
origin (11). A mechanism for RNA dimerization that relies on
multiple determinants that act sequentially would meet the
challenge of maintaining specificity while providing the redun-
dancy that might be expected for a critical biologic function.
We are currently extending our evaluation of the biologic and
structural roles played by these elements.
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